课题基金 / 基金详情

Gene Polymorphisms Predisposing to Infectious Diarrhea

Gene Polymorphisms Predisposing to Infectious Diarrhea
易患感染性腹泻的基因多态性
批准号:
6600837
负责人:
Pablo C Okhuysen
金额:
$12.25万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2007-12-31

项目摘要

项目成果

Pablo C Okhuysen的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):暴露于肠道病原体后,感染性腹泻的表现是可变的,取决于宿主和病原体因素。多种宿主因素调节感染的可能性或症状的严重程度,并且可以被分类为介导易感性的那些(即,宿主遗传因素,病原体受体),和损伤(即,液体和电解质通道的刺激、促炎细胞因子)。感染的消退取决于有助于控制和愈合阶段的因素(即,抗炎细胞因子和特异性免疫)。我们的中心假设是,遗传多态性,导致定性或定量的差异,这些介质中的一个或几个是部分负责发展感染和疾病后,暴露于肠道病原体。为此,我们将研究两个特征良好的感染性腹泻受试者群体。第一个研究小组将由来自发达国家的健康成年人组成,他们将前往腹泻细菌感染的风险地区。第二个研究组将由在德克萨斯大学休斯顿临床研究中心实验暴露于隐孢子虫的健康成年人组成。对于这两种情况,我们建议研究宿主基因的单核苷酸多态性(SNP),这些基因编码的蛋白质与易感性、疾病表现(损伤)的调节、根除(控制)和感染后的愈合相关。我们将重点关注三种具有不同病理生理学的潜在生物恐怖主义分子:肠毒素E。大肠杆菌引起的分泌性腹泻,肠聚集性E.大肠杆菌,一种引起炎症性腹泻的病原体,隐孢子虫是一种细胞内病原体。SNP将与肠道病原体的分离和临床疾病相关。SNPs的影响将在不同种族背景的背景下进行研究。感染的结果,因为它们涉及到主机的遗传因素的理解将用于设计生物防御干预措施,旨在改善风险评估。确定对肠道病原体的影响更敏感或更脆弱的人群,对于设计减少这些病原体可能导致疾病的影响的策略以及确定最有可能从预防、治疗和/或疫苗中受益的人群将是重要的。
英文摘要
DESCRIPTION (provided by applicant): After exposure to an enteropathogen, the manifestations of infectious diarrhea are variable and depend on host and pathogen factors. A variety of host factors modulate the likelihood of infection or severity of symptoms and can be categorized as those that mediate susceptibility (i.e., host genetic factors, pathogen receptors), and injury (i.e., stimulation of fluid and electrolyte channels, pro inflammatory cytokines). Resolution of infection is determined by factors that contribute to the phases of control and healing (i.e., anti-inflammatory cytokines and specific immunity). Our central hypothesis is that genetic polymorphisms that lead to qualitative or quantitative differences in one or several of these mediators are partially responsible for the development of infection and illness after exposure to enteric pathogens. To this end we will study two well-characterized populations of subjects with infectious diarrhea. The first study group will consist of healthy adults traveling from developed nations to areas of risk for infection with bacterial agents of diarrhea. The second study group will consist of healthy adults experimentally exposed to Cryptosporidium at the University of Texas - Houston Clinical Research Center. For both we propose to investigate host single nucleotide polymorphisms (SNPs) of genes that encode proteins that are associated with either susceptibility, modulation of disease manifestation (injury), eradication (control) and healing after infection. We will focus on three agents with potential for bioterrorism use by waterborne or food borne routes with distinct pathophysiology; enterotoxigenic E. coli a cause of secretory diarrhea, Enteroaggregative E. coli, a cause of inflammatory diarrhea and Cryptosporidium an intracellular pathogen. SNPs will be correlated with the isolation of an enteropathogen and clinical illness. The impact of SNPs will be examined in the context of different ethnic backgrounds. The understanding of the outcome of infection as they relate to host genetic factors will be of use in designing biodefense interventions that are directed towards improving risk assessment. The identification of populations that are more susceptible or vulnerable to the effects of enteric pathogens will be important in the design of strategies to decrease the impact that these agents may have in causing disease and defining the populations most likely to benefit from prevention, treatment and or vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mucosal determinants of Cryptosporidium infection
  • 批准号:
    10396594
  • 项目类别:
  • 资助金额:
    $55.71万
  • 财政年份:
    2019
  • 负责人:
    Pablo C Okhuysen
  • 依托单位:
Mucosal determinants of Cryptosporidium infection
  • 批准号:
    10160782
  • 项目类别:
  • 资助金额:
    $44.01万
  • 财政年份:
    2019
  • 负责人:
    Pablo C Okhuysen
  • 依托单位:
Mucosal determinants of Cryptosporidium infection
  • 批准号:
    10601135
  • 项目类别:
  • 资助金额:
    $55.71万
  • 财政年份:
    2019
  • 负责人:
    Pablo C Okhuysen
  • 依托单位:
IL-2 (PROLEUKIN) IN HIV+ PATIENTS IN A RANDOMIZED INTERNATIONAL TRIAL (ESPRIT)
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: